Previous Close | 746.2 |
1-Year Change | 26.74% |
6-Months Change | -3.09% |
3-Months Change | -19.05% |
Moving Avg (50d) | 882.57 |
Moving Avg (200d) | 834.99 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 0.671T |
Beta (3-Years) | 0.57 |
Revenue Growth (ttm) | 9.69% |
Net Profit Margin (ttm) | 15.55% |
Return On Assets (ttm) | 8.61% |
EPS (ttm) | 5.52 |
PE Ratio (ttm) | 135.18 |
Dividend Yield | 0.59% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named. As of October 2024,... Wikipedia